Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry Britta HöchsmannRegis Peffault de LatourJong Wook Lee Original Article Open access 05 September 2023 Pages: 2979 - 2988
Delay in treatment of adult hemophagocytic lymphohistiocytosis is associated with worse in-hospital outcomes Ali AbdelhayAmir MahmoudOmar Ammari Original Article 01 July 2023 Pages: 2989 - 2996
Alternative treatment modality for severe aplastic anemia in a resource-limited setting: a single-institution prospective cohort study from Upper Egypt Mervat A M YoussefMohammed H GhazalyMai A Abdelfattah Original Article Open access 13 September 2023 Pages: 2997 - 3006
Bleeding risk assessment in immune thrombocytopenia Kundan MishraAditya JandialPankaj Malhotra Original Article 23 September 2023 Pages: 3007 - 3014
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile Luca GuarneraEmiliano FabianiLuca Maurillo Original Article Open access 03 August 2023 Pages: 3015 - 3023
Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect Salvatore PerroneStefano ImperatoreMatteo Molica Original Article Open access 22 August 2023 Pages: 3025 - 3030
Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study Joana InfanteGraça EstevesJoão Forjaz de Lacerda Original Article Open access 31 August 2023 Pages: 3031 - 3037
Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study Zhuxin ZhangQinglin HuBing Han Original Article 08 September 2023 Pages: 3039 - 3047
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia Peter J P CroucherMaya RidingerAmer M. Zeidan Original Article Open access 13 September 2023 Pages: 3049 - 3059
Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation Qingya WangZeyin LiangYuan Li Original Article 04 September 2023 Pages: 3061 - 3074
Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studies Irit AviviNaama YekutielGabriel Chodick Original Article 30 August 2023 Pages: 3075 - 3081
Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group Julia von TresckowNikola HeylAnna Maria Fink Original Article Open access 26 June 2023 Pages: 3083 - 3090
Physical activity-related health competence and symptom burden for exercise prescription in patients with multiple myeloma: a latent profile analysis Rea KuehlMaximilian KoeppelJoachim Wiskemann Original Article Open access 24 June 2023 Pages: 3091 - 3102
Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia Hiroyuki KimuraMasahiro OnozawaTakanori Teshima Original Article 19 August 2023 Pages: 3103 - 3113
Prediction nomogram based on 18F-FDG PET/CT and clinical parameters for patients with diffuse large B-cell lymphoma Xiaojuan PengSisi YuZhuzhong Cheng Original Article 03 July 2023 Pages: 3115 - 3124
Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia Naveen C HegdeAnkit KumarAmol N Patil Original Article 13 July 2023 Pages: 3125 - 3132
Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring Taylor D. Coe-EisenbergAnthony J. PerissinottiLydia Benitez Original Article 22 July 2023 Pages: 3133 - 3141
“Sandwich” protocol based on modified SMILE regimen for children with newly extranodal NK/T cell lymphoma, nasal type: a single-arm, single-center clinical study Cheng-qi ShenGuo-qian HeXia Guo Original Article Open access 24 July 2023 Pages: 3143 - 3152
CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma Yuqi GongHongyan TongRen Zhou Original Article Open access 09 September 2023 Pages: 3153 - 3165
Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP Moonho KimYongchel AhnSang-Wook Yi Original Article 21 August 2023 Pages: 3167 - 3175
Cytopenia: a report of haplo-cord transplantation in twin brothers caused by a novel germline GATA1 mutation and family survey Xing-Hua SunQin LiuHui Jiang Original Article 18 July 2023 Pages: 3177 - 3184
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study Meng WuFengrong WangJun Zhu Original Article Open access 12 September 2023 Pages: 3185 - 3193
Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation Jingyu XuWenqiang YanGang An Original Article Open access 08 September 2023 Pages: 3195 - 3204
Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study Shan JiangXuan LuLinghui Xia Original Article 08 September 2023 Pages: 3205 - 3216
Excellent outcome of stem cell transplantation for sickle cell disease Tanja ValléeIrene SchmidMichael H. Albert Original Article Open access 19 September 2023 Pages: 3217 - 3227
A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation Yuling WuYue WangTing Liu Original Article 29 September 2023 Pages: 3229 - 3237
Association between ABO blood group/genotype and COVID-19 in a Japanese population Tatsuya KusumotoShotaro ChubachiKoichi Fukunaga Original Article 15 August 2023 Pages: 3239 - 3249
A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis Shixuan WangKebing LvFei Li Original Article Open access 10 August 2023 Pages: 3251 - 3259
Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data) Gabriela RomanováPetr SmejkalMiroslav Penka Original Article Open access 23 September 2023 Pages: 3261 - 3270
Alemtuzumab induced acquired hemophilia A in multiple sclerosis: a case report Hassan FawazMohammad Hassan HodrojAli Taher Letter to the Editor 22 July 2023 Pages: 3271 - 3273
Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia? Jiapei GaoJunyin GaoFengling Min Letter to the Editor Open access 31 July 2023 Pages: 3275 - 3276
Successful treatment of relapsed/refractory transformed aggressive B-cell lymphoma with polatuzumab vedotin combined with bendamustine and rituximab followed by non-myeloablative related HLA-haploidentical stem cell transplantation Shigeki KosugiMasatoshi KannoYasuyuki Inoue Letter to the Editor 10 August 2023 Pages: 3277 - 3278
Hemophagocytosis by multinucleated leukemic blasts, basophilia, and micromegakaryocytes in AML with TLS::ERG Xingqin HuangTing LiFang Long Letter to the Editor 02 August 2023 Pages: 3279 - 3281
Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation María LouzaoMaría Teresa VargasMaría Eva Mingot-Castellano Letter to the Editor 23 August 2023 Pages: 3283 - 3284
Quadruple stem cells transplantation of haploidentical bone marrow and PBSCs supporting by third-party umbilical cord blood and MSCs achieved excellent outcomes Chengxin LuoXiaohong LiShuangnian Xu Letter to the Editor 17 August 2023 Pages: 3285 - 3287
Recurrent arterial thrombosis as the primary symptom in a patient with polycythemia vera Jia-hao WenHua-liang RenChun-min Li Letter to the Editor 23 August 2023 Pages: 3289 - 3290
Daratumumab—a novel treatment strategy in relapsed/refractory acute leukemia Pronamee BorahNitin DayalRahul Naithani Letter to the Editor 09 August 2023 Pages: 3291 - 3293
Successful treatment by CAR T-cells in multi-refractory mantle cell lymphoma with central nervous system involvement Adrien CailletCaroline HouillierDamien Roos-Weil Letter to the Editor 15 August 2023 Pages: 3295 - 3297